Rosiglitazone maleate kinase inhibitor product blog
Tags: Kinase Inhibitor; Rosiglitazone maleate; Rosiglitazone maleate kinase inhibitor;
The Rosiglitazone maleate n/a (Catalog #MBS8506283) is an Inhibitor and is intended for research purposes only. The product is available for immediate purchase.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given inhibitor. We\'ve tested the Rosiglitazone maleate with the following immunoassay(s):
Testing Data
Rosiglitazone maleate (Avandia) is an anti-diabetic agent in the thiazolidinedione class of agents. Rosiglitazone maleate (Avandia) acts primarily by increasing insulin sensitivity. Rosiglitazone maleate (Avandia) improves glycemic control while reducing circulating insulin levels. Rosiglitazone is a member of the thiazolidinedione class of agents. They reduce glucose, fatty acid, and insulin blood concentrations. They work by binding to the peroxisome proliferator-activated receptors (PPARs). Thiazolidinediones enter the cell, bind to the nuclear receptors, and affect the expression of DNA. Rosiglitazone maleate (Avandia) also appears to have an anti-inflammatory effect in addition to its effect on insulin resistance.
Solubility: DMSO >=95 mg/mL - Water <1 mg/mL - Ethanol >=6 mg/mL. Formula: C18H19N3O3S.C4H4O4
CAS Number: 155141-29-0.